...
首页> 外文期刊>Surgical Endoscopy >Laparoscopic-assisted peritoneal dialysis catheter placement: a microinvasive technique.
【24h】

Laparoscopic-assisted peritoneal dialysis catheter placement: a microinvasive technique.

机译:腹腔镜辅助腹膜透析导管放置:一种微创技术。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Peritoneal dialysis is an alternate form of dialysis for patients with end-stage renal disease (ESRD). Although not as widely used as hemodialysis, peritoneal dialysis (PD) has clear advantages, especially those related to patient satisfaction and simplicity. The purpose of our study was to describe and look at the results of a microinvasive technique for placement of peritoneal dialysis catheters under laparoscopy. METHODS: From August 2003 to January 2006, 12 patients with ESRD underwent laparoscopic-assisted peritoneal dialysis (LAPD) catheter placement with the microinvasive technique at our institution. Data collected included age, gender, underlying renal disease, and length of operation. Followup was completed for all patients (at least 6 months) and catheter-related morbidity and mortality were also analyzed. RESULTS: There were 13 procedures performed (one patient had LAPD catheter placement twice). The average age was 45 years and the most common cause of ESRD was uncontrolled arterial hypertension. Procedural time averaged 33.6 min (range = 24-50 min). Peritoneal dialysis was introduced two weeks after the procedure and no dialysate leaks were observed. There were two catheter-related morbidities; both were catheter exit-site abscesses, one managed surgically with removal of the PD catheter and the other managed conservatively with culture-sensitive antimicrobials. Patient satisfaction was beyond acceptable in 92% of the patients (12 of 13). Average longevity of the catheter was 61 weeks (427 days). There were no mortalities. CONCLUSION: LAPD catheter placement is an easy technique with acceptable catheter longevity and minimal morbidity. The microinvasive technique leads to better patient satisfaction and cosmetic outcome without affecting its function. Therefore, we believe that by promoting microinvasive LAPD catheter placement, PD will gain more acceptance among doctors and patients.
机译:背景:腹膜透析是终末期肾脏疾病(ESRD)患者的另一种透析形式。腹膜透析(PD)尽管没有像血液透析那样广泛使用,但它具有明显的优势,尤其是与患者满意度和简便性有关的优势。我们研究的目的是描述和研究在腹腔镜下放置腹膜透析导管的微创技术的结果。方法:2003年8月至2006年1月,在我院采用微创技术对12例ESRD患者进行了腹腔镜辅助腹膜透析(LAPD)导管置入术。收集的数据包括年龄,性别,潜在的肾脏疾病和手术时间。所有患者的随访均已完成(至少6个月),并分析了与导管相关的发病率和死亡率。结果:共进行了13次手术(一名患者两次将LAPD导管置入)。平均年龄为45岁,ESRD的最常见原因是不受控制的动脉高血压。程序时间平均为33.6分钟(范围= 24-50分钟)。手术后两周开始进行腹膜透析,未观察到透析液渗漏。有两种与导管相关的发病率;两种都是导管出口部位脓肿,一种是通过手术切除PD导管进行手术,另一种是采用培养敏感性抗菌剂进行保守治疗。 92%的患者(13位中的12位)的患者满意度超出了可接受的范围。导管的平均寿命为61周(427天)。没有死亡。结论:LAPD导管置入术是一种简便的技术,具有可接受的导管寿命和最低的发病率。微创技术可在不影响其功能的情况下提高患者满意度和美容效果。因此,我们相信通过促进微创LAPD导管的放置,PD将获得医生和患者的更多认可。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号